Related Experiment Videos
Nifedipine for digitalis-induced arrhythmias
Summary
Nifedipine, a calcium antagonist, demonstrated anti-arrhythmic properties by converting ventricular tachycardia to sinus rhythm in dogs. This finding contrasts with previous beliefs and suggests nifedipine may act similarly to verapamil in cardiac conditions.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Nifedipine, a calcium channel blocker, was traditionally considered to lack anti-arrhythmic effects.
- This contrasts with verapamil, another calcium antagonist known for its anti-arrhythmic capabilities.
Purpose of the Study:
- To investigate the potential cardiac anti-arrhythmic properties of nifedipine.
- To compare nifedipine's effects on induced arrhythmias with those of verapamil.
Main Methods:
- Anesthetized dogs were used as a model.
- Ventricular tachycardia was induced using cardiac glycoside (K-strophanthoside).
- Nifedipine was administered intravenously to assess its efficacy.
Main Results:
- Nifedipine successfully converted K-strophanthoside-induced ventricular tachycardia to sinus rhythm in 4 out of 5 dogs.
- These results indicate nifedipine possesses anti-arrhythmic properties in this experimental model.
Conclusions:
- Nifedipine exhibits anti-arrhythmic effects, challenging previous assumptions.
- Nifedipine's efficacy in treating specific arrhythmias makes it comparable to verapamil in this context.
- Further research is needed to determine the clinical applicability in humans.